O46.002 Antepartum hemorrhage with coagulation defect, unspecified, second trimester

Name of the Condition

• Antepartum Hemorrhage with Coagulation Defect, Unspecified, Second Trimester

Summary

Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, typically after 20 weeks of gestation. When associated with a coagulation defect, the bleeding may be exacerbated by underlying issues with blood clotting, which can complicate management and increase risks to both the mother and fetus. This code specifies the condition occurs in the second trimester and does not specify the type of coagulation defect.

Causes

The coagulation defect in antepartum hemorrhage may arise from preexisting conditions such as inherited clotting disorders, acquired deficiencies (e.g., vitamin K deficiency), or complications like disseminated intravascular coagulation (DIC). These defects can be triggered by severe bleeding, infection, or other systemic issues that disrupt normal clotting mechanisms.

Risk Factors

• Preexisting clotting disorders (e.g., hemophilia, von Willebrand disease)
• Severe infection or sepsis
• Placental abruption or previa
• Trauma or injury to the abdomen
• Multiple pregnancies
• History of bleeding disorders or previous hemorrhage

Symptoms

• Vaginal bleeding (ranging from spotting to heavy flow)
• Excessive bruising or prolonged bleeding from minor injuries
• Fatigue or weakness (due to blood loss)
• Signs of coagulation issues, such as petechiae or uncontrolled bleeding

Diagnosis

Diagnosis involves assessing the bleeding pattern and evaluating coagulation status through blood tests (e.g., prothrombin time, partial thromboplastin time, fibrinogen levels). Imaging studies like ultrasound may be used to identify the source of bleeding, and fetal monitoring assesses well-being.

Treatment Options

Management focuses on stabilizing the mother, controlling bleeding, and addressing the coagulation defect. Interventions may include intravenous fluids, blood transfusions, clotting factor replacement, and monitoring for fetal distress. In severe cases, delivery may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding, the underlying coagulation defect, and fetal status. Close monitoring of maternal and fetal health is essential. Follow-up includes ongoing evaluation of coagulation parameters and assessment for recurrence in subsequent pregnancies.

Complications

• Severe maternal anemia or shock
• Fetal growth restriction or distress
• Preterm labor or delivery
• Increased risk of postpartum hemorrhage
• Long-term maternal or fetal morbidity

Lifestyle & Prevention

• Prenatal care to monitor for bleeding risks
• Avoiding trauma or injury to the abdomen
• Managing preexisting conditions (e.g., clotting disorders) with medical guidance
• Prompt reporting of any vaginal bleeding or unusual symptoms

When to Seek Professional Help

Seek immediate medical attention for heavy vaginal bleeding, severe abdominal pain, dizziness, or signs of shock (e.g., rapid heartbeat, low blood pressure). Fetal movement changes or reduced activity also warrant urgent evaluation.

Tips for Medical Coders

Document the trimester (second) and the presence of a coagulation defect without specifying the type. Ensure clinical notes support the diagnosis and exclude more specific codes if applicable. Verify that the bleeding is antepartum (after 20 weeks) and not related to labor or delivery.